October 24, 2015 Medications from plant with Legionnaires' bacteria are safe, manufacturer says The medications produced at a GlaxoSmithKline pharmaceutical plant are safe despite the decision to close the factory after the discovery of the bacteria that causes potentially fatal Legionnaires' disease, the company said Wednesday.
October 24, 2015 Stores prepare to widen access to Plan B pill Drugstores are preparing to change how they stock and sell a widely used emergency contraceptive after the Obama administration agreed to allow the pill to be sold over the counter to customers of all ages.
October 24, 2015 FDA approves first nonhormonal drug for hot flashes The Food and Drug Administration Friday approved the first nonhormonal drug designed to treat hot flashes, one of the most bothersome symptoms of menopause.
October 24, 2015 FDA announces voluntary recall for Specialty Compounding products The U.S. Food and Drug Administration said on Sunday that Specialty Compounding LLC will voluntary recall its full line of sterile products used to inject drugs, citing concerns about bacterial bloodstream infections.
October 24, 2015 FDA approves Sanofi/Regeneron cholesterol drug with limits The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
October 24, 2015 'Female Viagra' seen more a pace-setter than moneymaker The first U.S. treatment for low sexual desire in women, dubbed “female Viagra,” is more likely to help build a market for better future rival drugs than achieve the sales seen for Pfizer Inc’s famous little blue pill for men, industry experts said.
October 24, 2015 FDA panel votes to relax Avandia restrictions U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the biggest drug controversies in recent years.
October 24, 2015 FDA panel votes to keep severe warning on Pfizer anti-smoking drug Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.
October 24, 2015 Merck's insomnia drug moves a step closer to FDA approval Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.
October 24, 2015 Trial shows new drug tops Plavix for blood thinning The Medicines Co's experimental intravenous blood clot preventer Cangrelor, which is intended for use during angioplasty procedures, solidly outperformed commonly used Plavix in a pivotal late stage study, likely resurrecting the drug's prospects
